Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding
Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals
January 6, 2019
Veristat Partners with TRI For Risk-Based Monitoring Technology
November 5, 2018
Veristat Partners with TRI to Provide Centralized and Risk-Based Monitoring Technology to Their Biopharmaceutical Clients
Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma